1) Bierman P, Giglio P:Diagnosis and treatment of central nervous system involvement in non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 19:597-609, 2005
2) Doolittle ND, Abrey LE, Shenkier TN, Tali S, Bromberg JE, Neuwelt EA, Soussain C, Jahnke K, Johnston P, Illerhaus G, Schiff D, Batchelor T, Montoto S, Kraemer DF, Zucca E:Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma:an International Primary CNS Lymphoma Collaborative Group report. Blood 111:1085-1093, 2008
3) Fukui MB, Livstone BJ, Meltzer CC, Hamilton RL:Hemorrhagic presentation of untreated primary CNS lymphoma in a patient with AIDS. AJR Am J Roentgenol 170:1114-1115, 1998
4) Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM, Dunleavy K, Jaffe ES, Abati A, Stetler-Stevenson M, Wilson WH:High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement:the role of flow cytometry versus cytology. Blood 105:496-502, 2005
5) Kim IY, Jung S, Jung TY, Kang SS, Choi C:Primary central nervous system lymphoma presenting as an acute massive intracerebral hemorrhage:case report with immunohistochemical study. Surg Neurol 70:308-311, 2008
6) Kimura N, Ishibashi M, Masuda T, Morishige M, Abe T, Fujiki M, Kashima K, Kumamoto T:Primary central nervous system lymphoma with cortical laminar hemorrhage. J Neurol Sci 287:281-284, 2009
7) Passarin MG, Wen PY, Vattemi E, Buffone E, Ghimenton C, Bontempini L, Ottaviani S, Musso AM, Pedersini R:Intravascular lymphomatosis and intracerebral haemorrhage. Neurol Sci 31:793-797, 2010
8) Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M:Hemorrhage and VEGF expression in a case of primary CNS lymphoma. J Neurooncol 58:53-56, 2002
9) Streletz LJ, Terzic D, Salem K, Raza A, Deleu DT:CNS lymphoma masquerading as hemorrhagic stroke. Clin Neurol Neurosurg 114:262-264, 2012
10) The International Non-Hodgkin's Lymphoma Prognostic Factors Project:A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994, 1993
11) Villa D, Connors JM, Shenkier TN, Gascoyne RD, Sehn LH, Savage KJ:Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma:the impact of the addition of rituximab to CHOP chemotherapy. Ann Oncol 21:1046-1052, 2010